Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-000155
Filing Date
2022-01-03
Accepted
2022-01-03 16:30:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A brhc10032499_defa14a.htm DEFA14A 28081
2 image1.jpg GRAPHIC 85233
  Complete submission text file 0001140361-22-000155.txt   146625
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37568 | Film No.: 22502534
SIC: 2834 Pharmaceutical Preparations